A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

August 17, 2022

Primary Completion Date

June 23, 2025

Study Completion Date

June 23, 2025

Conditions
Advanced Solid TumorsMetastatic Solid Tumors
Interventions
DRUG

GDC-1971

Capsule or tablet administered orally.

DRUG

Atezolizumab

Administered as IV infusion.

DRUG

Omeprazole

Administered orally as tablet or capsule in the acid-reducing agent assessment.

Trial Locations (25)

1023

Auckland City Hospital, Auckland

2010

St Vincent's Hospital Sydney, Darlinghurst

3084

Austin Hospital, Heidelberg

3690

Border Medical Oncology, Wodonga

5042

Flinders Medical Centre, Bedford Park

6009

One Clinical Research Perth, Nedlands

10408

National Cancer Center, Goyang-si

28644

Chungbuk National University Hospital, Cheongju-si

X5000JHQ

Sanatorio Allende, Córdoba

F5300COE

Fundacion CORI para la Investigacion y Prevencion del Cancer, La Rioja

S2013SBK

Centro Medico IPAM, Rosario

81520-060

Liga Paranaense de Combate Ao Cancer - Hospital Erasto Gaertner, Curitiba

90035-903

Hospital de Clinicas de Porto Alegre HCPA PPDS, Pôrto Alegre

98700-000

ONCOSITE Centro de Pesquisa Clínica Em Oncologia, Ijuí

14784-400

Fundacao Pio XII Hospital de Cancer de Barretos, Barretos

17210-080

Fundação Doutor Amaral Carvalho - Hospital Amaral, Jaú

15090-000

Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto Hospital de Base - PPDS, São José do Rio Preto

01246-000

Instituto do Cancer do Estado de Sao Paulo - ICESP, São Paulo

03102-006

Instituto Brasileiro de Controle Do Câncer IBCC, São Paulo

T6G 1Z2

Cross Cancer Institute, Edmonton

K1H 8L6

Ottawa Hospital, Ottawa

M5G 2M9

Princess Margaret Cancer Centre, Toronto

03080

Seoul National University Hospital, Seoul

03722

Severance Hospital, Yonsei University Health System, Seoul

05505

Asan Medical Center - PPDS, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY